Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-13

Clinical Trial Update: A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy [Phase 3]

View source ↗

Summary

Phase 3 study comparing seltorexant to quetiapine XR as adjunctive therapy to antidepressants in adults and elderly with major depressive disorder and insomnia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine XR (quetiapine)
  • Seltorexant (seltorexant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED